Work

Association of Rash With Outcomes in a Randomized Phase II Trial Evaluating Cetuximab in Combination With Mitoxantrone Plus Prednisone After Docetaxel for Metastatic Castration-resistant Prostate Cancer

Year: 2012

Type: article

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2011.11.003

Authors: Mark T. Fleming, Guru Sonpavde, Michael Kolodziej, Sanjay Awasthi, Thomas E. Hutson, Danko Martincic, Ashutosh Rastogi, Steven R. Rousey, Ralph E. Weinstein, Matthew D. Galsky, William R. Berry, Yunfei Wang, Kristi A. Boehm, Lina Asmar, Mary A. Rauch, Tomasz M. Beer

Institutions: McKesson (United States), Virginia Oncology Associates, Texas Oncology, New York Oncology Hematology, University of North Texas Health Science Center, Cancer Care Northwest, Minnesota Oncology, Northwest Orthopaedic Specialists, Icahn School of Medicine at Mount Sinai, OHSU Knight Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2017663593

FWCI: 3.556

Cites: 50

Cited by: 33

Related to: 10